Key facts
- LifeNome’s last known valuation is $43.0M.
- It has raised $5.1M.
- Notable investors include Plug and Play Tech Center, ClearImpact Ventures, Coty, LG Nova, PepsiCo Greenhouse Collaborative Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for LifeNome
- ·The full record, as it builds
Funding rounds
No funding rounds for LifeNome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LifeNome
Provider of a precision health and longevity technology company specializing in modular, science-driven platforms for enterprises. The company platform delivers tailored wellness and preventive care solutions for healthcare, insurance, pharmaceutical, nutrition, and fitness sectors worldwide, enabling healthcare providers to enhance health outcomes and lower costs with actionable, data-driven insights in key areas.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 17
- Website
- lifenomeapi.com/
- Ownership
- Privately Held (backing)
LifeNome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LifeNome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LifeNome in its N-PORT filings yet. We sweep new filings monthly.